Posters

Reversible homonymous hemianopia and omegavyte: a clinical case report of occipital lobe hemorrhage

Poster Details

First Author: R.Faisal SUDAN

Co Author(s):                        

Abstract Details

Purpose:

To report a case of left homonymous hemianopia secondary to right occipital lobe hemorrhage.

Setting:

Alneelain University Faculty of Optometry and Visual Sciences Alneealain University eye hospital

Methods:

A 29-year-old lady came to the clinic complaining of peripheral visual aura with history of sudden spasmodic headache in right temporal bone before one month. Contrast computed tomography showed intracranial hemorrhage at right occipital cortex due to AV brain fistula which was detected by cerebral interventional angiography. She took oral administration of Omega Vyte 3.6.9 tablets for one month. A prospective observation study with analysis of diagnostic tests was performed. The patient was followed for two years with automated static perimetry.

Results:

The best corrected visual acuity was 0.00 Log in both eyes. Pupillary function, intraocular pressure, slit lamp bio-microscopy, funduscopy and optical coherence tomography were normal. In addition, automated static perimetry showed left homonymous hemianopia. However, after total absorption of hemorrhage the hemianopia reduced and symptoms relieved and patient was taking Omega Vyte 3.6.9 two times a day. When patient stopped administration of Omega tablets after 6 months. She complained of visual aura gain and the automated visual field detected severe hemianopia.

Conclusions:

Visual field test is important for patient with cerebral occipital hemorrhage and with any patient complaining of visual aura without neurological deficit. In addition, Omega Vyte 3.6.9 enhances reversible of hemianopia secondary to occipital cortex hemorrhage.

Financial Disclosure:

None